Table 3 Sensitivity and specificity of Decipher risk thresholds for predicting AP in biopsy cohort

From: Validation of the Decipher Test for predicting adverse pathology in candidates for prostate cancer active surveillance

Cut point

Proportion (%)a

Sensitivity (95% CI)

Specificity (95% CI)

0.45

17.7

28% (16–45%)

84% (78–88%)

0.40

22.9

34% (20–52%)

79% (73–83%)

0.35

32.3

50% (34–66%)

70% (64–76%)

0.30

45.5

56% (39–72%)

56% (50–62%)

0.25

57.5

78% (61–89%)

45% (39–52%)

0.20

66.9

88% (72–95%)

36% (30–42%)

  1. aProportion of patients with Decipher score greater than the cut point
  2. CI confidence interval
Back to article page